Dipeptidyl peptidase 4 inhibitors attenuate cardiac ischaemia-reperfusion injury in rats with diabetes mellitus type 2.

MLA

Bradic, Jovana, et al. “Dipeptidyl Peptidase 4 Inhibitors Attenuate Cardiac Ischaemia-Reperfusion Injury in Rats with Diabetes Mellitus Type 2.” Clinical and Experimental Pharmacology & Physiology, vol. 48, no. 4, Apr. 2021, pp. 575–84. EBSCOhost, https://doi.org/10.1111/1440-1681.13450.

APA

Bradic, J., Milosavljevic, I., Bolevich, S., Litvitskiy, P. F., Jeremic, N., Bolevich, S., Zivkovic, V., Srejovic, I., Jeremic, J., Jovicic, N., Mitrovic, S., & Jakovljevic, V. (2021). Dipeptidyl peptidase 4 inhibitors attenuate cardiac ischaemia-reperfusion injury in rats with diabetes mellitus type 2. Clinical and Experimental Pharmacology & Physiology, 48(4), 575–584. https://doi.org/10.1111/1440-1681.13450

Chicago

Bradic, Jovana, Isidora Milosavljevic, Stefani Bolevich, Peter F Litvitskiy, Nevena Jeremic, Sergey Bolevich, Vladimir Zivkovic, et al. 2021. “Dipeptidyl Peptidase 4 Inhibitors Attenuate Cardiac Ischaemia-Reperfusion Injury in Rats with Diabetes Mellitus Type 2.” Clinical and Experimental Pharmacology & Physiology 48 (4): 575–84. doi:10.1111/1440-1681.13450.